No cytogenetic effects of quinolone treatment in humans
Authors:
- 1 June 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (6) , 936-937
Abstract
Cytogenetic effects of ciprofloxacin (500 to 2,000 mg daily) and ofloxacin (200 mg daily) were studied in lymphocytes from 31 patients treated for 1 to 10 weeks. Blood samples for cytogenetic analysis were taken before the start of treatment from all patients, after 1 week from 25 patients, and after 2, 4, 6, and 10 weeks from six patients. No chromosome-damaging effect could be demonstrated in any treatment group. The mean aberration yields for each cytogenetic parameter studied and the total number of aberrations were all normal at each sampling occasion.Keywords
This publication has 6 references indexed in Scilit:
- Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growthAntimicrobial Agents and Chemotherapy, 1987
- 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitroAntimicrobial Agents and Chemotherapy, 1987
- Quinolones affect thymidine incorporation into the DNA of human lymphocytesAntimicrobial Agents and Chemotherapy, 1986
- A twin study of structural chromosome aberrations in lymphocytesCytogenetic and Genome Research, 1986
- Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.Proceedings of the National Academy of Sciences, 1985
- Relationship between sister chromatid exchanges and structural chromosome aberrations in lymphocytes of 100 individualsHereditas, 1982